share_log

Barrington Research Maintains Outperform on Cross Country Healthcare, Lowers Price Target to $19

Benzinga ·  Aug 9 00:54  · Ratings

Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $21 to $19.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment